Statins inhibit platelet PAR-1 receptors: The PAR-1 inhibition by statins (PARIS) trial

被引：0
|
作者：
Serebruany, V
Miller, M
Malinin, A
Pokov, A
Lowry, D
Hennekens, C
机构：
[1] Johns Hopkins Univ, HeartDrug Rsch LLC, Towson, MD USA
[2] Univ Maryland, Baltimore, MD 21201 USA
[3] Univ Miami, Sch Med, Miami, FL USA
[4] Midatlan Cardiovasc Associates, Towson, MD USA
来源：
CIRCULATION | 2005年 / 112卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3113
引用
收藏
页码：U727 / U727
页数：1
相关论文
共 50 条
  • [41] Regulation of Cell Polarity by PAR-1/MARK Kinase
    Wu, Youjun
    Griffin, Erik E.
    PROTEIN KINASES IN DEVELOPMENT AND DISEASE, 2017, 123 : 365 - +
  • [42] Vascular effects of PAR-1 agonism in vivo in man
    Gudmundsdottir, IJ
    Megson, IL
    Ludlam, C
    Fox, KA
    Webb, DJ
    Newby, DE
    ATHEROSCLEROSIS, 2006, 186 (02) : S6 - S6
  • [43] Cleavage of protease-activated receptor-1 (PAR-1) and platelet activation by α- and γ-thrombins
    Nyarko, KA
    Freedman, J
    Song, YQ
    Gentry, PA
    Ofosu, FA
    THROMBOSIS AND HAEMOSTASIS, 1999, : 817 - 817
  • [44] The role of PAR-1 and PAR-2 in corneal epithelial inflammatory responses
    Strand, JL
    Song, PI
    Kang, Y
    Kolot, A
    Lang, R
    Armstrong, CA
    Ansel, JC
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A15 - A15
  • [45] Vorapaxar: emerging evidence and clinical questions in a new era of PAR-1 inhibition
    Ungar, Leo
    Rodriguez, Fatima
    Mahaffey, Kenneth W.
    CORONARY ARTERY DISEASE, 2016, 27 (07) : 604 - 615
  • [46] Cell polarity: Posterior par-1 prevents proteolysis
    Benton, R
    St Johnston, D
    CURRENT BIOLOGY, 2002, 12 (14) : R479 - R481
  • [47] PAR-1 helps Wnt to get rid of JNK
    Valerie Depraetere
    Nature Cell Biology, 2001, 3 : E158 - E158
  • [48] Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
    Damiano, BP
    Cheung, WM
    Santulli, RJ
    Fung-Leung, WP
    Ngo, K
    Ye, RD
    Darrow, AL
    Derian, CK
    De Garavilla, L
    Andrade-Gordon, P
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 288 (02): : 671 - 678
  • [49] PAR-1 is required for morphogenesis of the Caenorhabditis elegans vulva
    Hurd, D
    Kemphues, KJ
    DEVELOPMENTAL BIOLOGY, 2003, 253 (01) : 54 - 65
  • [50] Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1)
    Nantermet, PG
    Barrow, JC
    Lundell, GF
    Pellicore, JM
    Rittle, KE
    Young, M
    Freidinger, RM
    Connolly, TM
    Condra, C
    Karczewski, J
    Bednar, RA
    Gaul, SL
    Gould, RJ
    Prendergast, K
    Selnick, HG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) : 319 - 323
12345